Search Login Register

Octreotide (Sandostatin) Summary

Description: A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.

Also Known As: Sandostatin; Octreotide Acetate; Compound 201-995; Octreotide Acetate Salt; SAN 201-995 Show All >>

Networked: 4121 relevant articles (689 outcomes, 772 trials/studies) for this Drug

Key Diseases for which Octreotide is Relevant

  1. Neoplasms (Cancer) : 93 outcomes 106 studies in 897 results
  2. Acromegaly : 92 outcomes 98 studies in 508 results
  3. Diarrhea : 59 outcomes 29 studies in 170 results
  4. Carcinoid Tumor (Carcinoid) : 55 outcomes 44 studies in 349 results
  5. Hemorrhage : 48 outcomes 54 studies in 240 results
Show All >>

Drugs Related to Octreotide

  1. Somatostatin (Somatotropin Release-Inhibiting Factor)
  2. lanreotide (Somatuline)
  3. Somatostatin Receptors (Somatostatin Receptor)
  4. Octreotide (Sandostatin)
  5. Hormones
  6. Thyrotropin (Thyroid-Stimulating Hormone)
  7. Insulin (Novolin)
  8. Growth Hormone (Somatotropin)
  9. Insulin-Like Growth Factor I (IGF-1)
  10. everolimus
Show All >>

Therapies Related to Octreotide

  1. Drug Therapy (Chemotherapy)
  2. Sclerotherapy
  3. Injections
  4. Palliative Care (Palliative Medicine)
  5. Pancreaticoduodenectomy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.